Filing Details

Accession Number:
0001214659-21-010459
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-13 18:00:23
Reporting Period:
2021-10-11
Accepted Time:
2021-10-13 18:00:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1721484 Longeveron Inc. LGVN Pharmaceutical Preparations (2834) 472174146
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1845308 Rock Soffer 1951 Nw 7Th Avenue
Suite 520
Miami FL 33136
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-11 3,900 $3.45 35,757 No 4 P Direct
Common Stock Acquisiton 2021-10-12 4,000 $3.57 39,757 No 4 P Direct
Common Stock Acquisiton 2021-10-13 12,000 $3.76 51,757 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighed average of open-market purchase transactions ranging from $3.44 to 3.48. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Company or a security holder of the Company.
  2. Represents the weighed average of open-market purchase transactions ranging from $3.57 to 3.58. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Company or a security holder of the Company.
  3. Represents the weighed average of open-market purchase transactions ranging from $3.71 to 3.80. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Company or a security holder of the Company.
  4. Amount includes 5,000 Restricted Stock Units subject to vesting.